These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18722961)

  • 1. Additive effect of dorzolamide hydrochloride to patients taking travoprost: a retrospective study.
    Boyer S; Gay D
    Optometry; 2008 Sep; 79(9):501-4. PubMed ID: 18722961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC; Konstas AG; Nelson LA; Kruft B
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
    Maruyama K; Shirato S
    J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%.
    Feldman RM; Tanna AP; Gross RL; Chuang AZ; Baker L; Reynolds A; Prager TC;
    Ophthalmology; 2007 Jul; 114(7):1248-54. PubMed ID: 17509688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
    Bournias TE; Lai J
    Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined therapy in glaucoma treatment: travoprost 0.004% and brinzolamid].
    Popović Suić S; Vukojević N; Cerovski B; Jukić T
    Acta Med Croatica; 2006; 60(2):101-3. PubMed ID: 16848197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the role of travoprost 0.004% ophthalmic solution in the management of open angle glaucoma and ocular hypertensive patients.
    Chiselită D;
    Oftalmologia; 2007; 51(2):81-6. PubMed ID: 17937041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adjunctive therapy with brinzolamide in patients on travoprost treatment].
    Babić N; Andreić V; Miljković A; Canadanović V; Barisić S
    Med Pregl; 2011; 64(5-6):310-4. PubMed ID: 21789924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
    Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA
    Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Postoperative behavior of intraocular pressure after posterior Nd:YAG laser capsulotomy--critical evaluation in preventive administration of local carbonic anhydrase II inhibitor dorzolamide hydrochloride (Trusopt)].
    Lachmann C; Jörg KM; Trinkmann R
    Klin Monbl Augenheilkd; 1998 Dec; 213(6):326-30. PubMed ID: 10048009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The hypotensive action and side effects of the carboanhydrase inhibitor dorzolamide hydrochloride].
    Egorov AE
    Vestn Oftalmol; 1996; 112(2):3-4. PubMed ID: 9045485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of the European Glaucoma Prevention Study.
    Miglior S; Zeyen T; Pfeiffer N; Cunha-Vaz J; Torri V; Adamsons I;
    Ophthalmology; 2005 Mar; 112(3):366-75. PubMed ID: 15745761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
    Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
    J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of dorzolamide as added therapy in glaucoma patients with maximum tolerated drug therapy. A pilot study].
    Denk PO; Knorr M; Kriegerowski M; Thiel HJ
    Klin Monbl Augenheilkd; 1997 Jun; 210(6):360-4. PubMed ID: 9333661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-four-hour intraocular pressure control with the travoprost/timolol maleate fixed combination compared with travoprost when both are dosed in the evening in primary open-angle glaucoma.
    Konstas AG; Mikropoulos D; Haidich AB; Ntampos KS; Stewart WC
    Br J Ophthalmol; 2009 Apr; 93(4):481-5. PubMed ID: 19019932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.
    Yildirim N; Sahin A; Gultekin S
    J Glaucoma; 2008; 17(1):36-9. PubMed ID: 18303382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of twice-daily and three-times-daily dosing of dorzolamide in ocular hypertension and primary open-angle glaucoma patients treated with latanoprost.
    Lupinacci AP; Netland PA; Fung KH; Evans D; Zhao Y
    Adv Ther; 2008 Mar; 25(3):231-9. PubMed ID: 18369537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained effect of travoprost on diurnal and nocturnal intraocular pressure.
    Sit AJ; Weinreb RN; Crowston JG; Kripke DF; Liu JH
    Am J Ophthalmol; 2006 Jun; 141(6):1131-3. PubMed ID: 16765686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of visual function under treatment with topical antiglaucoma agents and systemic vasodilators. Clinical study on glaucoma patients].
    Popa SA; Bucătariu PM; Azoicăhi D; Costin D; Manole A; Matei M; Merchez M
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):455-9. PubMed ID: 21870740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.